Terray Therapeutics unveils game-changing platform for drug discovery
Endpoints News - 15-Feb-2022Combining AI with innovative chemistry to tackle the data bottleneck in medicine development
Amber Tong
Editor at Endpoints News
Her coverage varies daily but as a Hong Kong native, she is particularly excited about drug development in China. A graduate of Rice University, her work has appeared in Houstonia Magazine, Governing Magazine and The Chautauquan Daily. Amber is based in Hong Kong.
Details last updated 02-Aug-2020
Articles written by Amber Tong
Omega Therapeutics raises $85m for Epigenomic Controllers
Endpoints News - 29-Jul-2020New gene expression therapy for various targets, with clinical trial planned for 2021
